Harnessing rna potential in neuromuscular care
WHEN
Monday, 8 September
Start time
19:10 (BST)
Symposium overview
This symposium is designed to provide UK healthcare professionals with a comprehensive understanding of the Avidity Biosciences’ AOC (Antibody Oligonucleotide Conjugate) platform and its emerging role in the treatment of neuromuscular disorders. The programme explores current unmet needs in DM1, FSHD, and DMD and introduces innovative mechanisms and potential applications of AOC technology in these diseases. Through expert-led discussions and scientific insights, the symposium will emphasise the importance of this emerging platform in advancing care for individuals living with neuromuscular disorders—particularly those who currently lack disease-modifying treatment options or face significant unmet medical needs.
AGENDA
19:10 (10 mins)
exploring the AOC Platform
Presenter: Prof Laurent Servais
19:20 (10 mins)
The Evolving Landscape of Neuromuscular Disorders: Considerations for Clinical Practice
Panel:
Prof Laurent Servais,
Dr Channa Hewamadduma,
Dr Enrico Buiardini
Presenters & Panel
prof Laurent Servais
dr channa hewamadduma
dr Enrico bugiardini